ID | 60193 |
Sort Key | 4
|
Title Alternative | The 2018 Incentive Award of the Okayama Medical Association in General Medical Science (2018 Yuuki Prize)
|
FullText URL | |
Author |
Kato, Yuka
Center for Innovation Clinical Medicine, Okayama University Hospital
Kaken ID
|
Note | 平成30年度岡山医学会賞紹介記事 (The 2018 Okayama Medical Association Awards)
受賞対象論文 : Kato Y, Ninomiya K, Ohashi K, Tomida S, Makimoto G, Watanabe H, Kudo K, Matsumoto S, Umemura S, Goto K, Ichihara E, Ninomiya T, Kubo T, Sato A, Hotta K, Tabata M, Toyooka S, Maeda Y, Kiura K : Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions. Cancer Sci (2018) 109, 3149-3158.
|
Publication Title |
Journal of Okayama Medical Association
|
Published Date | 2020-04-01
|
Volume | volume132
|
Issue | issue1
|
Publisher | 岡山医学会
|
Publisher Alternative | Okayama Medical Association
|
Start Page | 10
|
End Page | 12
|
ISSN | 0030-1558
|
NCID | AN00032489
|
Content Type |
Journal Article
|
Related Url | isVersionOf https://doi.org/10.4044/joma.132.10
|
OAI-PMH Set |
岡山大学
|
language |
Japanese
|
Copyright Holders | Copyright (c) 2020 岡山医学会
|
File Version | publisher
|
Refereed |
True
|
DOI | |
NAID | |
Eprints Journal Name | joma
|